Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024
Offer reference number: CM/TNS/24/5711
CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Accord-UK Ltd | 00079585 | ~£230,000,000 estimated from lot values | - |
| Amgen Ltd | 02354269 | ~£230,000,000 estimated from lot values | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£230,000,000 estimated from lot values | - |
| Janssen-Cilag Ltd | 01027904 | ~£230,000,000 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Sandoz Ltd | 01547204 | ~£230,000,000 estimated from lot values | - |
| Thornton and Ross Ltd | 00185947 | ~£230,000,000 estimated from lot values | - |
Government spending data: These suppliers have received £64,772,323 in 2,045 payments (over £25k) from Department of Health and Social Care, Guy's and St Thomas' NHS FT, East Sussex Healthcare NHS Trust, Worcestershire Acute Hospitals NHS Trust, United Lincolnshire Hospitals NHS Trust and 15 more public bodies (2010-08-03 to 2026-03-31).